BUSINESS● LOW23h ago · Oct 16, 2026, 6:31 PM
Alkermes reinstated Buy at Truist on narcolepsy opportunity
Seeking Alpha Tech · global
Alkermes' stock rating was reinstated to "Buy" by Truist, based on opportunities related to narcolepsy. This indicates a positive outlook from analysts on the company's financial prospects and drug development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS1h agoAmerica’s $40 trillion debt is coming for your walletThe HillBUSINESS1h agoKWA administrative fee on water tankers hits civic body’s water supply hardThe Hindu